Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. GDTC.NASDAQ

CytoMed Therapeutics Limited Ordinary Shares (GDTC NASDAQ) stock market data APIs

$1.89 0.08(4.4%) as of July 26, 2024
Price chart is built with Anychart

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company was incorporated in 2018 and is headquartered in Singapore.

CytoMed Therapeutics Limited Ordinary Shares Financial Data Overview

1.81
1.89
-
1.99
1.68
1.68-5.5
20 887 K
11 540 K
508 K
0
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GDTC',
Type: 'Common Stock',
Name: 'CytoMed Therapeutics Limited Ordinary Shares',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01BM32FR8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1873093',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-04-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

CytoMed Therapeutics Limited Ordinary Shares Fundamental Data is available in our Financial Data APIs

  • Net Revenue 508 K
  • EBITDA -3 463 885
  • Earnings Per Share -0.29
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get CytoMed Therapeutics Limited Ordinary Shares Earnings via APIs

  • Latest Release 2024-05-29
  • EPS/Forecast -0.05

Get CytoMed Therapeutics Limited Ordinary Shares End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com